A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

Canada

Ascendis Investigational Site, Montreal

Denmark

Ascendis Investigational Site, Copenhagen

France

Ascendis Investigational Site, Paris

Ireland

Ascendis Investigational Site, Dublin

United Kingdom

Ascendis Investigational Site, Norwich